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The Use of Transgenic Mice for Environmental
Health Research
One of the most remarkable technical
advances in biomedical research has been
the development of transgenic mice.
Transgenic mice can be made by using a
transgene constructed with recombinant
DNA techniques to randomly insert a new
gene into the genome of the mouse or by
mutating a targeted gene. A randomly
inserted transgene usually adds to the
genetic repertoire ofthe animal, whereas a
targeted mutation usually produces a func-
tional "knock-out" of a gene. Transgenic
mice are a unique tool for understanding
how interactions between individual genes
and the environment affect human health.
Randomly Inserted Transgenes
Most transgenic mice are made by inject-
ing a transgene into fertilized eggs. The
eggs are removed from the oviduct, and an
ultrafine glass pipet is used to inject a solu-
tion containing a few hundred copies of
the transgene DNA into the nucleus. The
injected eggs are put into the oviduct of a
surrogate mother, and pups are born 19
days later. Some of these mice will have
the transgene in their genome, and their
descendants for generations to follow will
also carry the transgene. A mouse receiv-
ing the transgene is referred to as a trans-
genic founder; its descendants are members
ofa genetically identical transgenic line.
The methods to make transgenic mice
were developed in the early 1980s byJohn
Gordon and by Ralph Brinster and Richard
Palmiter and their co-workers. The first
use of transgenic mice was to study gene
function in the whole animal; in particular,
how and why a spe-
cific gene is "turned
on in some tissues
and "turned off" in
others. Although
all of the cells in
the body contain
an identical set of
genes, some genes
are active in only
one or a few tissues.
It is this diversity
of gene expression
that produces the
distinct cell types
and tissues of the
body, making a
muscle cell differ-
ent from a liver
cell. Mighty mouse.Transgeni
The two main parts of a gene are the
regulatory region and the protein-coding
region. When the right combination of
proteins binds to specific sites along the
DNA in the regulatory region, the gene is
switched on, and the protein-coding region
becomes active. Transgenic mice have
been used to identify the exact parts ofthe
regulatory region that turn a gene on in a
particular tissue. To do this, a reporter
gene is made by fusing different parts of
the regulatory region ofone gene onto the
protein-coding region of another gene.
The protein-coding region is usually taken
from a gene not found in the mouse, often
the 3-galactosidase gene of bacteria. The
0-galactosidase gene codes for an enzyme
that produces a blue color when exposed to
a specific chromogenic substrate called X-
Gal. Only those mice that receive the part
of the regulatory region needed to activate
the gene will develop the blue color in the
appropriate tissue.
The knowledge gained about the regu-
lation ofexpression ofspecific genes using
transgenic mice is likely to have important
implications for future environmental
health.research. For example, the level of
activity ofa gene that codes for a detoxify-
ing enzyme may determine a person's sus-
ceptibility to a toxic environmental agent.
This hypothesis could be tested in different
lines oftransgenic mice designed to express
the gene at high or low levels. Such mice
might also be used to detect when exposure
occurs, define the mechanisms leading to
the toxic effects, and develop treatments
for individuals exposed to the agent.
ic mice are powerful toolsforsolving human gene puzzles.
Transgenic mice have also proven to be
valuable for understanding the roles of
proteins. Using transgenic mice, it is pos-
sible to increase or decrease the amount of
specific proteins, express proteins at a dif-
ferent time or in a different tissue than
normal, and test the function of a modi-
fied protein. For example, one ofthe first
transgenic mice lines had a transgene with
the regulatory region of the mouse metal-
lothionein gene spliced to the coding
region of the rat growth-hormone gene.
These mice grew to be twice as large as
normal mice. This study dramatically
demonstrated that the protein coded by
the transgene was functional in the mouse
and that rat growth hormone produced an
additive effect on mouse growth hormone.
Transgenic mice offer new ways to
identify and characterize environmental,
occupational, genetic, dietary, and other
factors that induce neoplastic processes.
Two classes of genes have been identified
that influence tumor formation: Tumor-
suppressor genes act in a negative manner
to control cell growth, and oncogenes
appear to function in a positive fashion.
One gene being studied is the p53 tumor-
suppressor gene, whose product appears to
be involved in maintaining genomic stabil-
ity. Mutations that inactivate the p53
gene are the most common genetic alter-
ation observed in a wide variety ofhuman
cancers. Compared to normal animals,
mice that carry a mutant p53 transgene are
much more susceptible to lung tumor for-
mation after treatment with a chemical
carcinogen. Tumors from these mice are
being examined to identify additional
tumor-suppressor genes that interact with
the transgene. These studies may identify
novel genes involved in cancer develop-
ment and help deter-
,, mine the relationship
A between genetic diver-
2 sity and variable sus-
ceptibility to cancer.
The protein-coding
region of oncogenes
has been introduced
into mice with regula-
tory sequences that tar-
get certain tissues and
allow activation of the
transgene by a specific
chemical or genetic
mutation. For exam-
ple, transgenic mice
carrying an activated
oncogene that is sensi-
tive to carcinogenic
and promoter effects of
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environmental chemicals applied to the
skin are being studied. These mice re-
spond to certain chemicals with a different
pattern of papillomas or carcinomas than
animals lacking the transgene.
Such transgenic mice provide a sensi-
tive way to study the rate and pattern of
tumor formation, the range of tissues
affected, and the interaction of different
factors that influence tumor formation.
Researchers hope to make some transgenic
mice more sensitive to the carcinogenic
effects ofcertain chemicals than other ani-
mals to more rapidly detect carcinogens.
Big Blue transgenic mice were devel-
oped in a collaborative effort between
NIEHS and Stratagene. All ofthe cells in
these mice contain an inactive P-galactosi-
dase reporter transgene. Exposure of the
mice to mutagenic chemicals causes muta-
tions that activate the transgene. These
mutations are identified by isolating DNA
from various transgenic mouse tissues,
transferring it to bacterial hosts, and scor-
ing the activity ofP-galactosidase in vitro.
This approach is a relatively rapid and effi-
cient way to screen in vivo for chemical
mutagens. In addition, mouse DNA can
be extracted from the bacterial colonies,
and the specific nature ofthe mutation can
be determined from the nucleotide
sequence.
Transgenic mice have also been used to
identify previously unknown genes.
Transgenes are incorporated randomly into
the genome ofthe fertilized egg and occa-
sionally disrupt a gene by being inserted
into its regulatory or protein-coding
region. The result is mice with genetic
mutations such as limb deformities, infer-
tility, reversal of left-right asymmetry, or
lethal developmental anomalies. However,
the transgene serves as a marker for the site
of mutation and can be used to clone the
disrupted gene. This allows identification
of a candidate gene for comparable birth
defects in humans. Such findings have led
to unique approaches for identifying genes
invdlved in development. In "gene trap-
ping," transgenes that lack regulatory
sequences but that contain the bacterial 5-
galactosidase coding region are injected.
These transgenes are expressed when they
are incorporated into a location in the
genome that allows them to be activated by
the regulatory portion of a gene. The X-
Gal labeling approach can then be used to
define the temporal and spatial expression
ofthe trapped gene, and the transgene can
be used as a marker for cloning that gene.
The NIEHS, National Academy of
Sciences Institute of Laboratory Animal
Resources (ILAR), and Oak Ridge Na-
tional Laboratory Human Genome Group
have combined efforts to establish a data-
base that catalogs information on trans-
How to build a better mouse. Scientists are using two innovative techniques to create transgenic
animals.
genic animals. Researchers use standard-
ized nomenclature to submit information
about their transgenic animal lines. The
computerized database includes details of
the transgenic constructs, expression pat-
terns oftransgenes, the morphological and
functional effects of the transgenes, and
other information about the genetics and
availability ofthe animals. [For additional
information about the transgenic animal
database, contact Karin Schneider at Oak
Ridge National Laboratories, (615) 574-
6529.]
Targeted Gene Mutations
It became possible to mutate specific genes
in the late 1980s with the convergence of
advances in developmental, reproductive,
and molecular biology. Targeted muta-
tions have allowed the development of
mouse models of human genetic diseases
and tests of the roles of specific genes by
causing loss of function ("gene knock-
out"). One key technical advance was the
development of methods for growing
embryonic stem cells from mouse embryos
in tissue culture. When embryonic stem
cells are injected into mouse embryos at an
early stage of development, they affect all
the tissues of the mouse. Embryos are
removed on the third day ofdevelopment,
injected with embryonic stem cells, and
transferred to surrogate mothers. Some of
the mice born are chimeras, composed ofa
mixture of cells from the original embryo
and from embryonic stem cells. The
sperm or eggs in the chimeric mouse give
rise to offspring carrying the embryonic
stem cell genes.
The other key advance in producing
mice with genes knocked out was tech-
niques to cause mutations that block the
function of specific genes in embryonic
stem cells. This first requires cloning the
gene and modifying it using genetic engi-
neering methods. The modifications inac-
tivate the normal function ofthe gene, but
add the ability to inactivate a toxic drug.
The normal gene in an embryonic stem
cell is replaced with the modified gene by
a procedure known as homologous recom-
bination. Embryonic stem cells that con-
tain the modified gene are selected by
their resistance to the drug and subse-
quently injected into mouse embryos to
make chimeric mice.
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Coat-color markers are used to identify
the mice carrying the genes from embryon-
ic stem cells. Most embryonic stem cells
were originally derived from mice with
white coats. When the embryonic stem
cells are injected into embryos from mice
with a black coat, the chimeric mice that
result have a mixture ofblack and white or
light brown hair. When these chimeric
mice are mated to mice with a black coat,
the offspring receiving a copy ofthe genes
from embryonic stem cells often have tan
coats. However, other coat colors are pos-
sible for offspring of the original chimeric
mouse due to the multiple genes involved
in determining mouse coat colors. Since
an offspring of a chimeric mouse inherits
only one copy ofeach embryonic stem cell
chromosome, additional matings are neces-
sary to produce offspring with two copies
of the mutated gene in the absence of the
normal gene.
The gene responsible for cystic fibrosis
was one of the first to be targeted for
knock-out to produce a mouse model ofa
human disease. Cystic fibrosis is caused
primarily by a defective chloride-channel
gene. Beverly Koller at the University of
North Carolina School of Medicine suc-
cessfully targeted a mutation to this gene.
The mice produced have defects in chlo-
ride secretion and sodium absorption that
affect the fluid environment of the lining
ofthe lungs and airways and other epithe-
lial tissues such as those in the digestive
and reproductive tracts. These mice have
been a major advantage in studying cystic
fibrosis. The mice are being used to better
understand how mutations in the gene lead
to the disease, test different drug treat-
ments, and develop gene therapy strategies.
Inherited mutations in the p53 tumor-
suppressor gene give rise to the Li-
Fraumeni syndrome in humans, character-
ized by a profound susceptibility to several
forms of cancer. When the p53 gene was
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mutated in mice by Lawrence Donehower
and Allan Bradley at the Baylor College of
Medicine, these animals developed nor-
mally but were prone to spontaneous
development ofa variety ofneoplasms by 6
months of age. About 75% of mice with
mutations that inactivate both copies of
the p53 gene develop multiple types of
tumors by this age.
One of the surprising results of many
gene knock-out studies is that the tissues in
which the proteins are usually expressed
are not disrupted, and there are no other
obvious effects ofthe mutation. An expla-
nation frequently proposed has been that
some proteins are redundant, and closely
related proteins can replace the ones elimi-
nated. Other explanations are that the ani-
mal can function normally without the
protein, that loss of a protein might up-
regulate compensatory mechanisms, or
that proteins may be expressed in tissues
where they have no function at all. Harold
Erickson of Duke University argues that
protein synthesis is cheap from the per-
spective of cellular metabolism, but that
gene control mechanisms are expensive.
He suggests that unless the protein is dele-
terious to the cell, there is no compelling
reason for the cell not to make a superflu-
ous or junk protein. However, the num-
ber of examples where gene knock-outs
have no obvious effects are small, and it
remains to be seen if there are subtle but
important effects in these animals.
Gene knock-out technology is still at
an early stage of development and is diffi-
cult and inefficient. To make it more
usable, the availability and stability of
embryonic stem cell lines, the efficiency of
targeting mutations to specific genes in
embryonic stem cells, and the frequency by
which chimeras produce offspring that
carry the gene knock-out must be im-
proved. The recent development of em-
bryonic germ cell lines from primordial
germ cells may reduce some of these tech-
nical problems. In addition, gene knock-
outs are often made by removing part ofa
gene and inserting a piece offoreign DNA
in its place, using a drug-resistance gene
isolated from bacteria. Continuing im-
provements in technology are allowing
more subtle changes to be introduced into
genes, such as producing specific deletions
or substitutions in the regulatory or coding
regions that mimic human disease muta-
tions without permanently inserting for-
eign DNA. As more genes are identified
from experimental studies and the human
genome project, transgenic mice will pro-
vide more powerful ways to test howgenes
interact with the environment to affect
human health.
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